Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3308682rdf:typepubmed:Citationlld:pubmed
pubmed-article:3308682lifeskim:mentionsumls-concept:C0019425lld:lifeskim
pubmed-article:3308682lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:3308682lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3308682lifeskim:mentionsumls-concept:C0751435lld:lifeskim
pubmed-article:3308682lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:3308682lifeskim:mentionsumls-concept:C0178655lld:lifeskim
pubmed-article:3308682lifeskim:mentionsumls-concept:C2700116lld:lifeskim
pubmed-article:3308682lifeskim:mentionsumls-concept:C0076281lld:lifeskim
pubmed-article:3308682pubmed:issue2lld:pubmed
pubmed-article:3308682pubmed:dateCreated1987-11-17lld:pubmed
pubmed-article:3308682pubmed:abstractTextWe have identified deficient biopterin synthesis in four probands and one sib with persistent postnatal hyperphenylalaninemia. The metabolic findings were associated with a benign clinical presentation and normal biopterin level in cerebrospinal fluid in the newborn period, indicating the peripheral (hepatic) form of this autosomal recessive phenotype. Impaired development was apparent at 3 months in one proband not treated early. Treatment with oral tetrahydropterin restored adequate phenylalanine hydroxylase activity; it also maintained or improved CNS function. The deficient enzyme in these subjects is 6-pyruvoyl tetrahydropterin synthase (PTS). Erythrocyte activity of PTS in homozygotes (or compound heterozygotes) is less than 10% of normal. Heterozygotes have 20%-50% of normal PTS activity (enzyme phenotype), a finding compatible with a range of gene dosage effects, some abnormal. The metabolic phenotype in heterozygotes (urine biopterin excretion) did not correlate with erythrocyte PTS activity. The complex relationship between erythrocyte PTS activity, and biopterin synthesis in these families indicates genetic heterogeneity at the PTS locus.lld:pubmed
pubmed-article:3308682pubmed:languageenglld:pubmed
pubmed-article:3308682pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3308682pubmed:citationSubsetIMlld:pubmed
pubmed-article:3308682pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3308682pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3308682pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3308682pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3308682pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3308682pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3308682pubmed:statusMEDLINElld:pubmed
pubmed-article:3308682pubmed:monthOctlld:pubmed
pubmed-article:3308682pubmed:issn0340-6717lld:pubmed
pubmed-article:3308682pubmed:authorpubmed-author:ScriverC RCRlld:pubmed
pubmed-article:3308682pubmed:authorpubmed-author:NiederwieserA...lld:pubmed
pubmed-article:3308682pubmed:authorpubmed-author:KaplanPPlld:pubmed
pubmed-article:3308682pubmed:authorpubmed-author:HORAF BFBlld:pubmed
pubmed-article:3308682pubmed:issnTypePrintlld:pubmed
pubmed-article:3308682pubmed:volume77lld:pubmed
pubmed-article:3308682pubmed:ownerNLMlld:pubmed
pubmed-article:3308682pubmed:authorsCompleteYlld:pubmed
pubmed-article:3308682pubmed:pagination168-71lld:pubmed
pubmed-article:3308682pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:meshHeadingpubmed-meshheading:3308682-...lld:pubmed
pubmed-article:3308682pubmed:year1987lld:pubmed
pubmed-article:3308682pubmed:articleTitleHyperphenylalaninemia due to deficiency of 6-pyruvoyl tetrahydropterin synthase. Unusual gene dosage effect in heterozygotes.lld:pubmed
pubmed-article:3308682pubmed:affiliationMcGill University, Children's Hospital Research Institute, Montreal, Quebec, Canada.lld:pubmed
pubmed-article:3308682pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3308682pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:3308682pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5805entrezgene:pubmedpubmed-article:3308682lld:entrezgene